Literature DB >> 17082305

The first randomized trial of aspirin for heart attack and the advent of systematic overviews of trials.

Peter Elwood1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082305      PMCID: PMC1633560          DOI: 10.1177/014107680609901121

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  8 in total

1.  Prevention of coronary and cerebral thrombosis.

Authors:  L L CRAVEN
Journal:  Miss Valley Med J       Date:  1956-09

2.  Impaired platelet-connective-tissue reaction in man after aspirin ingestion.

Authors:  H J Weiss; L M Aledort
Journal:  Lancet       Date:  1967-09-02       Impact factor: 79.321

3.  Two in-vivo studies comparing high and low aspirin dosage.

Authors:  J R O'Brien; V Tulevski; M Etherington
Journal:  Lancet       Date:  1971-02-20       Impact factor: 79.321

4.  Case-control studies in the evaluation of drug-induced illness.

Authors:  H Jick; M P Vessey
Journal:  Am J Epidemiol       Date:  1978-01       Impact factor: 4.897

5.  A randomized, controlled trial of aspirin in persons recovered from myocardial infarction.

Authors: 
Journal:  JAMA       Date:  1980-02-15       Impact factor: 56.272

6.  Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study.

Authors:  H D Lewis; J W Davis; D G Archibald; W E Steinke; T C Smitherman; J E Doherty; H W Schnaper; M M LeWinter; E Linares; J M Pouget; S C Sabharwal; E Chesler; H DeMots
Journal:  N Engl J Med       Date:  1983-08-18       Impact factor: 91.245

7.  A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction.

Authors:  P C Elwood; A L Cochrane; M L Burr; P M Sweetnam; G Williams; E Welsby; S J Hughes; R Renton
Journal:  Br Med J       Date:  1974-03-09

8.  Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-30
  8 in total
  4 in total

1.  An historical perspective on meta-analysis: dealing quantitatively with varying study results.

Authors:  Keith O'Rourke
Journal:  J R Soc Med       Date:  2007-12       Impact factor: 5.344

2.  Learning how to control biases in studies to identify adverse effects of drugs: a brief personal history.

Authors:  Hershel Jick
Journal:  J R Soc Med       Date:  2009-04       Impact factor: 5.344

3.  Reflections on the design and analysis of clinical trials and meta-analyses in the 1970s and 1980s.

Authors:  Richard Peto
Journal:  J R Soc Med       Date:  2019-02       Impact factor: 5.344

Review 4.  Technological advances in preclinical meta-research.

Authors:  Alexandra Bannach-Brown; Kaitlyn Hair; Zsanett Bahor; Nadia Soliman; Malcolm Macleod; Jing Liao
Journal:  BMJ Open Sci       Date:  2021-07-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.